These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36419911)

  • 1. Seroprevalence of SARS CoV-2 among children after the second surge (June 2021) in a rural district of South India: Findings and lessons from a population-based survey.
    George CE; Inbaraj LR; Rajukutty S; Joan RF; Muthuraj S; Chandrasingh S
    Front Pediatr; 2022; 10():997684. PubMed ID: 36419911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
    George CE; Inbaraj LR; Rajukutty S; Joan RF; Suseeladevi AK; Muthuraj S; Chandrasingh S
    PLoS One; 2022; 17(3):e0265236. PubMed ID: 35271669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
    PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
    Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    medRxiv; 2020 Oct; ():. PubMed ID: 33140066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
    Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of COVID-19 infection in a rural district of South India: A population-based seroepidemiological study.
    Inbaraj LR; George CE; Chandrasingh S
    PLoS One; 2021; 16(3):e0249247. PubMed ID: 33788873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children's Hospital in India.
    Venkataraman A; Balasubramanian S; Putilibai S; Lakshan Raj S; Amperayani S; Senthilnathan S; Manoharan A; Sophi A; Amutha R; Sadasivam K; Goenka A; Ramanan AV
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33693892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
    Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
    JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru.
    Reyes-Vega MF; Soto-Cabezas MG; Cárdenas F; Martel KS; Valle A; Valverde J; Vidal-Anzardo M; Falcón ME; Munayco CV;
    EClinicalMedicine; 2021 Apr; 34():100801. PubMed ID: 33817611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
    Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
    BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
    Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
    BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021.
    Lyimo E; Fougeroux C; Malabeja A; Mbwana J; Hayuma PM; Liheluka E; Turner L; Gesase S; Lavstsen T; Lusingu JPA; Minja DTR; Wang CW
    BMC Infect Dis; 2022 Nov; 22(1):846. PubMed ID: 36371172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Prevalence and Geographic Heterogeneity of SARS-CoV-2 Infection: Findings of the First Serosurvey in Uttar Pradesh, India.
    Namasivayam V; Jain A; Agrawal V; Prakash R; Dehury B; Becker M; Blanchard J; Isac S; Prasad AM
    J Epidemiol Glob Health; 2021 Dec; 11(4):364-376. PubMed ID: 34734386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
    Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study.
    Muro A; Belhassen-García M; Muñoz Bellido JL; Lorenzo Juanes H; Vicente B; Pendones J; Adserias J; Sánchez Hernández G; Rodríguez Rosa M; Vicente Villardón JL; Burguillo J; López Andaluz J; Martín Oterino JA; García Criado FJ; Barbero F; Morales AI; Galindo Villardón P; González Sarmiento R; On Behalf Of The Diancusal Team
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
    Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
    Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.